Condition: GLIOMA SUSCEPTIBILITY 1


rs28933368 in ERBB2;MIR4728 gene and GLIOMA SUSCEPTIBILITY 1 PMID 15457249 2004 Lung cancer: intragenic ERBB2 kinase mutations in tumours.

rs1057519903 in H3-3A gene and GLIOMA SUSCEPTIBILITY 1 PMID 23539269 2013 Histone H3.3. mutations drive pediatric glioblastoma through upregulation of MYCN.

PMID 22286061 2012 Driver mutations in histone H3.3 and chromatin remodelling genes in paediatric glioblastoma.

PMID 22286216 2012 Somatic histone H3 alterations in pediatric diffuse intrinsic pontine gliomas and non-brainstem glioblastomas.

rs1057519904 in H3C11 gene and GLIOMA SUSCEPTIBILITY 1 PMID 22286216 2012 Somatic histone H3 alterations in pediatric diffuse intrinsic pontine gliomas and non-brainstem glioblastomas.

rs1057519906 in IDH2 gene and GLIOMA SUSCEPTIBILITY 1 PMID 19228619 2009 IDH1 and IDH2 mutations in gliomas.

PMID 25495392 2015 IDH2 mutation in gliomas including novel mutation.

rs776893978 in LZTR1 gene and GLIOMA SUSCEPTIBILITY 1 PMID 30442766 2018 LZTR1 is a regulator of RAS ubiquitination and signaling.